The constitutive activation of nuclear factor kappa B (NF-κB) pathway, located downstream of TCR signaling, has been implicated to play a key role in tumor resistance to apoptosis in CTCL (57). The gene discussed is NFKB1; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.